Physician profile
Sameer Mehta
NPI 1710990908
$150,042.73
in general payments reported to CMS, 2019-2025
8 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $20K · 2021: $141 · 2022: $2,636 · 2023: $30K · 2024: $30K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $83K · Food and Beverage: $26.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $82,500.00 |
| Food and Beverage | $26.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $97,500.00 | 2020-2025 | General - Atherectomy |
| Medtronic Vascular, INC. | $44,824.52 | 2019-2020 | |
| Cardiovascular Systems INC. | $7,239.12 | 2020-2022 | |
| Comsort, INC | $150.00 | 2019 | |
| Abbott Laboratories | $149.99 | 2022 | |
| Shockwave Medical, INC | $141.13 | 2021 | |
| Cvrx, INC. | $26.93 | 2024 | Barostim Neo System |
| Ultradent Products INC | $11.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.